nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—CYP1A2—Imiquimod—skin cancer	0.101	0.135	CbGbCtD
Clomifene—CYP1A1—Dacarbazine—skin cancer	0.0947	0.127	CbGbCtD
Clomifene—CYP2E1—Dacarbazine—skin cancer	0.0732	0.098	CbGbCtD
Clomifene—CYP2A6—Fluorouracil—skin cancer	0.065	0.087	CbGbCtD
Clomifene—ABCB1—Vismodegib—skin cancer	0.0611	0.0818	CbGbCtD
Clomifene—CYP1A2—Vemurafenib—skin cancer	0.0552	0.0739	CbGbCtD
Clomifene—CYP3A4—Imiquimod—skin cancer	0.0528	0.0707	CbGbCtD
Clomifene—CYP3A4—Temozolomide—skin cancer	0.0528	0.0707	CbGbCtD
Clomifene—CYP1A2—Dacarbazine—skin cancer	0.0423	0.0567	CbGbCtD
Clomifene—CYP3A4—Vismodegib—skin cancer	0.0366	0.049	CbGbCtD
Clomifene—ABCB1—Dactinomycin—skin cancer	0.0321	0.043	CbGbCtD
Clomifene—CYP3A4—Vemurafenib—skin cancer	0.0289	0.0387	CbGbCtD
Clomifene—CYP1A2—Fluorouracil—skin cancer	0.0248	0.0332	CbGbCtD
Clomifene—ABCB1—Docetaxel—skin cancer	0.0166	0.0222	CbGbCtD
Clomifene—CYP3A4—Docetaxel—skin cancer	0.00993	0.0133	CbGbCtD
Clomifene—EBP—Sorafenib—Vismodegib—skin cancer	0.0052	1	CbGdCrCtD
Clomifene—Procaine—SCN10A—skin cancer	0.00334	1	CrCbGaD
Clomifene—EBP—female reproductive system—skin cancer	0.00158	0.0814	CbGeAlD
Clomifene—CYP1A1—skin epidermis—skin cancer	0.00118	0.061	CbGeAlD
Clomifene—ESR1—blood vessel—skin cancer	0.00104	0.0537	CbGeAlD
Clomifene—Cerebrovascular accident—Imiquimod—skin cancer	0.000966	0.00429	CcSEcCtD
Clomifene—CYP11A1—connective tissue—skin cancer	0.000944	0.0487	CbGeAlD
Clomifene—Migraine—Imiquimod—skin cancer	0.000931	0.00413	CcSEcCtD
Clomifene—Myalgia—Vismodegib—skin cancer	0.000921	0.00409	CcSEcCtD
Clomifene—Arthralgia—Vismodegib—skin cancer	0.000921	0.00409	CcSEcCtD
Clomifene—Foetor hepaticus—Docetaxel—skin cancer	0.000915	0.00406	CcSEcCtD
Clomifene—Irritability—Imiquimod—skin cancer	0.000903	0.00401	CcSEcCtD
Clomifene—SIGMAR1—nipple—skin cancer	0.000851	0.0439	CbGeAlD
Clomifene—Tenderness—Fluorouracil—skin cancer	0.000825	0.00366	CcSEcCtD
Clomifene—Embolism—Docetaxel—skin cancer	0.000809	0.00359	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Vismodegib—skin cancer	0.000804	0.00357	CcSEcCtD
Clomifene—Pulmonary embolism—Temozolomide—skin cancer	0.000781	0.00347	CcSEcCtD
Clomifene—Phlebitis—Bleomycin—skin cancer	0.00078	0.00346	CcSEcCtD
Clomifene—Cyst—Docetaxel—skin cancer	0.000777	0.00345	CcSEcCtD
Clomifene—Leukocytosis—Fluorouracil—skin cancer	0.000766	0.0034	CcSEcCtD
Clomifene—Liver disorder—Docetaxel—skin cancer	0.000762	0.00338	CcSEcCtD
Clomifene—Fatigue—Vismodegib—skin cancer	0.000761	0.00338	CcSEcCtD
Clomifene—Constipation—Vismodegib—skin cancer	0.000755	0.00335	CcSEcCtD
Clomifene—Pain—Vismodegib—skin cancer	0.000755	0.00335	CcSEcCtD
Clomifene—ESR1—neck—skin cancer	0.000744	0.0384	CbGeAlD
Clomifene—Phlebitis—Dactinomycin—skin cancer	0.000728	0.00323	CcSEcCtD
Clomifene—Erythema multiforme—Vemurafenib—skin cancer	0.000726	0.00322	CcSEcCtD
Clomifene—Neoplasm—Temozolomide—skin cancer	0.000706	0.00314	CcSEcCtD
Clomifene—Dermatitis atopic—Docetaxel—skin cancer	0.000702	0.00312	CcSEcCtD
Clomifene—Cerebrovascular accident—Bleomycin—skin cancer	0.000686	0.00305	CcSEcCtD
Clomifene—Scotoma—Docetaxel—skin cancer	0.000684	0.00304	CcSEcCtD
Clomifene—Alopecia—Vemurafenib—skin cancer	0.000678	0.00301	CcSEcCtD
Clomifene—Mental disability—Temozolomide—skin cancer	0.000678	0.00301	CcSEcCtD
Clomifene—KCNH2—nipple—skin cancer	0.000677	0.0349	CbGeAlD
Clomifene—Photophobia—Fluorouracil—skin cancer	0.000676	0.003	CcSEcCtD
Clomifene—Erythema—Vemurafenib—skin cancer	0.000668	0.00297	CcSEcCtD
Clomifene—CYP11A1—female reproductive system—skin cancer	0.000666	0.0344	CbGeAlD
Clomifene—Thrombophlebitis—Temozolomide—skin cancer	0.000655	0.00291	CcSEcCtD
Clomifene—Back pain—Vemurafenib—skin cancer	0.000646	0.00287	CcSEcCtD
Clomifene—Deafness—Temozolomide—skin cancer	0.000634	0.00281	CcSEcCtD
Clomifene—Asthenia—Vismodegib—skin cancer	0.000633	0.00281	CcSEcCtD
Clomifene—Visual impairment—Imiquimod—skin cancer	0.000631	0.0028	CcSEcCtD
Clomifene—Eye pain—Temozolomide—skin cancer	0.000628	0.00279	CcSEcCtD
Clomifene—Pruritus—Vismodegib—skin cancer	0.000624	0.00277	CcSEcCtD
Clomifene—Erythema multiforme—Imiquimod—skin cancer	0.000619	0.00275	CcSEcCtD
Clomifene—CYP19A1—connective tissue—skin cancer	0.000614	0.0317	CbGeAlD
Clomifene—Tinnitus—Imiquimod—skin cancer	0.00061	0.00271	CcSEcCtD
Clomifene—Flushing—Imiquimod—skin cancer	0.000608	0.0027	CcSEcCtD
Clomifene—Hot flush—Temozolomide—skin cancer	0.000606	0.00269	CcSEcCtD
Clomifene—Diarrhoea—Vismodegib—skin cancer	0.000604	0.00268	CcSEcCtD
Clomifene—Thrombophlebitis—Fluorouracil—skin cancer	0.000604	0.00268	CcSEcCtD
Clomifene—Menopausal symptoms—Temozolomide—skin cancer	0.000601	0.00267	CcSEcCtD
Clomifene—Arrhythmia—Imiquimod—skin cancer	0.000585	0.0026	CcSEcCtD
Clomifene—CYP1A2—nipple—skin cancer	0.00058	0.0299	CbGeAlD
Clomifene—Alopecia—Imiquimod—skin cancer	0.000578	0.00257	CcSEcCtD
Clomifene—CYP1A1—nipple—skin cancer	0.000572	0.0295	CbGeAlD
Clomifene—Erythema—Imiquimod—skin cancer	0.00057	0.00253	CcSEcCtD
Clomifene—Arthralgia—Vemurafenib—skin cancer	0.000569	0.00253	CcSEcCtD
Clomifene—Myalgia—Vemurafenib—skin cancer	0.000569	0.00253	CcSEcCtD
Clomifene—Diplopia—Temozolomide—skin cancer	0.000567	0.00252	CcSEcCtD
Clomifene—Vomiting—Vismodegib—skin cancer	0.000561	0.00249	CcSEcCtD
Clomifene—Affect lability—Temozolomide—skin cancer	0.000558	0.00248	CcSEcCtD
Clomifene—Rash—Vismodegib—skin cancer	0.000557	0.00247	CcSEcCtD
Clomifene—CYP11A1—head—skin cancer	0.000556	0.0287	CbGeAlD
Clomifene—Dermatitis—Vismodegib—skin cancer	0.000556	0.00247	CcSEcCtD
Clomifene—Back pain—Imiquimod—skin cancer	0.000551	0.00245	CcSEcCtD
Clomifene—Mood swings—Temozolomide—skin cancer	0.000537	0.00238	CcSEcCtD
Clomifene—ESR1—connective tissue—skin cancer	0.000533	0.0275	CbGeAlD
Clomifene—Nausea—Vismodegib—skin cancer	0.000524	0.00233	CcSEcCtD
Clomifene—Pulmonary embolism—Docetaxel—skin cancer	0.000519	0.00231	CcSEcCtD
Clomifene—Hepatocellular injury—Docetaxel—skin cancer	0.000519	0.00231	CcSEcCtD
Clomifene—Syncope—Imiquimod—skin cancer	0.000511	0.00227	CcSEcCtD
Clomifene—ESR1—epithelium—skin cancer	0.000506	0.0261	CbGeAlD
Clomifene—Palpitations—Imiquimod—skin cancer	0.000504	0.00224	CcSEcCtD
Clomifene—Loss of consciousness—Imiquimod—skin cancer	0.000501	0.00222	CcSEcCtD
Clomifene—Irritability—Fluorouracil—skin cancer	0.000499	0.00221	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000497	0.00221	CcSEcCtD
Clomifene—SIGMAR1—mammalian vulva—skin cancer	0.000497	0.0256	CbGeAlD
Clomifene—Convulsion—Imiquimod—skin cancer	0.000494	0.00219	CcSEcCtD
Clomifene—Abdominal distension—Temozolomide—skin cancer	0.000493	0.00219	CcSEcCtD
Clomifene—Hypertension—Imiquimod—skin cancer	0.000492	0.00218	CcSEcCtD
Clomifene—Arthralgia—Imiquimod—skin cancer	0.000485	0.00215	CcSEcCtD
Clomifene—Myalgia—Imiquimod—skin cancer	0.000485	0.00215	CcSEcCtD
Clomifene—Chest pain—Imiquimod—skin cancer	0.000485	0.00215	CcSEcCtD
Clomifene—Anxiety—Imiquimod—skin cancer	0.000483	0.00215	CcSEcCtD
Clomifene—Fatigue—Vemurafenib—skin cancer	0.00047	0.00209	CcSEcCtD
Clomifene—Neoplasm—Docetaxel—skin cancer	0.00047	0.00209	CcSEcCtD
Clomifene—Constipation—Vemurafenib—skin cancer	0.000466	0.00207	CcSEcCtD
Clomifene—Oedema—Imiquimod—skin cancer	0.000465	0.00206	CcSEcCtD
Clomifene—Lightheadedness—Docetaxel—skin cancer	0.000465	0.00206	CcSEcCtD
Clomifene—Shock—Imiquimod—skin cancer	0.000458	0.00203	CcSEcCtD
Clomifene—Tachycardia—Imiquimod—skin cancer	0.000454	0.00201	CcSEcCtD
Clomifene—Pollakiuria—Temozolomide—skin cancer	0.000453	0.00201	CcSEcCtD
Clomifene—Weight increased—Temozolomide—skin cancer	0.000446	0.00198	CcSEcCtD
Clomifene—Phlebitis—Docetaxel—skin cancer	0.000438	0.00194	CcSEcCtD
Clomifene—Thrombophlebitis—Docetaxel—skin cancer	0.000436	0.00193	CcSEcCtD
Clomifene—Hepatitis—Dactinomycin—skin cancer	0.000434	0.00193	CcSEcCtD
Clomifene—CYP19A1—female reproductive system—skin cancer	0.000433	0.0223	CbGeAlD
Clomifene—Flushing—Bleomycin—skin cancer	0.000432	0.00192	CcSEcCtD
Clomifene—Body temperature increased—Vemurafenib—skin cancer	0.000431	0.00191	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000424	0.00188	CcSEcCtD
Clomifene—Deafness—Docetaxel—skin cancer	0.000422	0.00187	CcSEcCtD
Clomifene—Insomnia—Imiquimod—skin cancer	0.000421	0.00187	CcSEcCtD
Clomifene—Paraesthesia—Imiquimod—skin cancer	0.000418	0.00185	CcSEcCtD
Clomifene—Dyspnoea—Imiquimod—skin cancer	0.000415	0.00184	CcSEcCtD
Clomifene—Alopecia—Bleomycin—skin cancer	0.000411	0.00182	CcSEcCtD
Clomifene—ABCB1—blood vessel—skin cancer	0.000411	0.0212	CbGeAlD
Clomifene—Erythema multiforme—Dactinomycin—skin cancer	0.00041	0.00182	CcSEcCtD
Clomifene—Erythema—Bleomycin—skin cancer	0.000405	0.0018	CcSEcCtD
Clomifene—Hot flush—Docetaxel—skin cancer	0.000403	0.00179	CcSEcCtD
Clomifene—Flushing—Dactinomycin—skin cancer	0.000403	0.00179	CcSEcCtD
Clomifene—Hypersensitivity—Vemurafenib—skin cancer	0.000402	0.00178	CcSEcCtD
Clomifene—Fatigue—Imiquimod—skin cancer	0.000401	0.00178	CcSEcCtD
Clomifene—Menopausal symptoms—Docetaxel—skin cancer	0.0004	0.00177	CcSEcCtD
Clomifene—Visual disturbance—Docetaxel—skin cancer	0.000398	0.00177	CcSEcCtD
Clomifene—Pain—Imiquimod—skin cancer	0.000398	0.00177	CcSEcCtD
Clomifene—Hepatitis—Temozolomide—skin cancer	0.000392	0.00174	CcSEcCtD
Clomifene—Asthenia—Vemurafenib—skin cancer	0.000391	0.00174	CcSEcCtD
Clomifene—ESR1—lymphoid tissue—skin cancer	0.00039	0.0201	CbGeAlD
Clomifene—CYP11A1—lymph node—skin cancer	0.00039	0.0201	CbGeAlD
Clomifene—Pruritus—Vemurafenib—skin cancer	0.000386	0.00171	CcSEcCtD
Clomifene—CYP1A1—epithelium—skin cancer	0.000385	0.0199	CbGeAlD
Clomifene—Alopecia—Dactinomycin—skin cancer	0.000383	0.0017	CcSEcCtD
Clomifene—Visual impairment—Temozolomide—skin cancer	0.000378	0.00168	CcSEcCtD
Clomifene—Erythema—Dactinomycin—skin cancer	0.000378	0.00168	CcSEcCtD
Clomifene—ESR1—female reproductive system—skin cancer	0.000376	0.0194	CbGeAlD
Clomifene—Diarrhoea—Vemurafenib—skin cancer	0.000373	0.00166	CcSEcCtD
Clomifene—Migraine—Docetaxel—skin cancer	0.000371	0.00165	CcSEcCtD
Clomifene—Erythema multiforme—Temozolomide—skin cancer	0.000371	0.00165	CcSEcCtD
Clomifene—Urticaria—Imiquimod—skin cancer	0.000369	0.00164	CcSEcCtD
Clomifene—Body temperature increased—Imiquimod—skin cancer	0.000368	0.00163	CcSEcCtD
Clomifene—CYP1A1—skin of body—skin cancer	0.000366	0.0189	CbGeAlD
Clomifene—Tinnitus—Temozolomide—skin cancer	0.000366	0.00162	CcSEcCtD
Clomifene—Flushing—Temozolomide—skin cancer	0.000364	0.00162	CcSEcCtD
Clomifene—CYP19A1—head—skin cancer	0.000361	0.0187	CbGeAlD
Clomifene—Dizziness—Vemurafenib—skin cancer	0.000361	0.0016	CcSEcCtD
Clomifene—Vomiting—Vemurafenib—skin cancer	0.000347	0.00154	CcSEcCtD
Clomifene—Alopecia—Temozolomide—skin cancer	0.000347	0.00154	CcSEcCtD
Clomifene—Myalgia—Bleomycin—skin cancer	0.000345	0.00153	CcSEcCtD
Clomifene—Chest pain—Bleomycin—skin cancer	0.000345	0.00153	CcSEcCtD
Clomifene—Rash—Vemurafenib—skin cancer	0.000344	0.00153	CcSEcCtD
Clomifene—Dermatitis—Vemurafenib—skin cancer	0.000344	0.00152	CcSEcCtD
Clomifene—Hypersensitivity—Imiquimod—skin cancer	0.000343	0.00152	CcSEcCtD
Clomifene—Headache—Vemurafenib—skin cancer	0.000342	0.00152	CcSEcCtD
Clomifene—Erythema—Temozolomide—skin cancer	0.000341	0.00152	CcSEcCtD
Clomifene—KCNH2—female reproductive system—skin cancer	0.000339	0.0175	CbGeAlD
Clomifene—CYP1A1—mammalian vulva—skin cancer	0.000334	0.0172	CbGeAlD
Clomifene—Asthenia—Imiquimod—skin cancer	0.000334	0.00148	CcSEcCtD
Clomifene—Oedema—Bleomycin—skin cancer	0.00033	0.00147	CcSEcCtD
Clomifene—Back pain—Temozolomide—skin cancer	0.00033	0.00147	CcSEcCtD
Clomifene—Pruritus—Imiquimod—skin cancer	0.000329	0.00146	CcSEcCtD
Clomifene—Nausea—Vemurafenib—skin cancer	0.000324	0.00144	CcSEcCtD
Clomifene—Arrhythmia—Fluorouracil—skin cancer	0.000323	0.00143	CcSEcCtD
Clomifene—Vision blurred—Temozolomide—skin cancer	0.000322	0.00143	CcSEcCtD
Clomifene—Myalgia—Dactinomycin—skin cancer	0.000321	0.00143	CcSEcCtD
Clomifene—Alopecia—Fluorouracil—skin cancer	0.000319	0.00142	CcSEcCtD
Clomifene—Diarrhoea—Imiquimod—skin cancer	0.000318	0.00141	CcSEcCtD
Clomifene—Erythema—Fluorouracil—skin cancer	0.000315	0.0014	CcSEcCtD
Clomifene—ESR1—head—skin cancer	0.000314	0.0162	CbGeAlD
Clomifene—Oedema—Dactinomycin—skin cancer	0.000308	0.00137	CcSEcCtD
Clomifene—Dizziness—Imiquimod—skin cancer	0.000308	0.00137	CcSEcCtD
Clomifene—Vertigo—Temozolomide—skin cancer	0.000307	0.00136	CcSEcCtD
Clomifene—Palpitations—Temozolomide—skin cancer	0.000302	0.00134	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000301	0.00134	CcSEcCtD
Clomifene—Paraesthesia—Bleomycin—skin cancer	0.000297	0.00132	CcSEcCtD
Clomifene—Weight increased—Docetaxel—skin cancer	0.000297	0.00132	CcSEcCtD
Clomifene—Vision blurred—Fluorouracil—skin cancer	0.000297	0.00132	CcSEcCtD
Clomifene—Convulsion—Temozolomide—skin cancer	0.000296	0.00131	CcSEcCtD
Clomifene—Vomiting—Imiquimod—skin cancer	0.000296	0.00131	CcSEcCtD
Clomifene—Hypertension—Temozolomide—skin cancer	0.000295	0.00131	CcSEcCtD
Clomifene—Dyspnoea—Bleomycin—skin cancer	0.000295	0.00131	CcSEcCtD
Clomifene—Rash—Imiquimod—skin cancer	0.000293	0.0013	CcSEcCtD
Clomifene—Dermatitis—Imiquimod—skin cancer	0.000293	0.0013	CcSEcCtD
Clomifene—Headache—Imiquimod—skin cancer	0.000291	0.00129	CcSEcCtD
Clomifene—Arthralgia—Temozolomide—skin cancer	0.000291	0.00129	CcSEcCtD
Clomifene—Myalgia—Temozolomide—skin cancer	0.000291	0.00129	CcSEcCtD
Clomifene—Anxiety—Temozolomide—skin cancer	0.00029	0.00129	CcSEcCtD
Clomifene—CYP1A1—female reproductive system—skin cancer	0.000286	0.0148	CbGeAlD
Clomifene—Renal failure—Docetaxel—skin cancer	0.000286	0.00127	CcSEcCtD
Clomifene—Jaundice—Docetaxel—skin cancer	0.000283	0.00126	CcSEcCtD
Clomifene—KCNH2—head—skin cancer	0.000283	0.0146	CbGeAlD
Clomifene—Pain—Bleomycin—skin cancer	0.000283	0.00125	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000281	0.00125	CcSEcCtD
Clomifene—Oedema—Temozolomide—skin cancer	0.000279	0.00124	CcSEcCtD
Clomifene—Nausea—Imiquimod—skin cancer	0.000276	0.00123	CcSEcCtD
Clomifene—Convulsion—Fluorouracil—skin cancer	0.000273	0.00121	CcSEcCtD
Clomifene—CYP2E1—lymphoid tissue—skin cancer	0.00027	0.014	CbGeAlD
Clomifene—Chest pain—Fluorouracil—skin cancer	0.000268	0.00119	CcSEcCtD
Clomifene—Myalgia—Fluorouracil—skin cancer	0.000268	0.00119	CcSEcCtD
Clomifene—Fatigue—Dactinomycin—skin cancer	0.000266	0.00118	CcSEcCtD
Clomifene—Pain—Dactinomycin—skin cancer	0.000263	0.00117	CcSEcCtD
Clomifene—Urticaria—Bleomycin—skin cancer	0.000262	0.00117	CcSEcCtD
Clomifene—Body temperature increased—Bleomycin—skin cancer	0.000261	0.00116	CcSEcCtD
Clomifene—Hepatitis—Docetaxel—skin cancer	0.000261	0.00116	CcSEcCtD
Clomifene—CYP2E1—female reproductive system—skin cancer	0.000261	0.0135	CbGeAlD
Clomifene—Oedema—Fluorouracil—skin cancer	0.000257	0.00114	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000254	0.00113	CcSEcCtD
Clomifene—CYP19A1—lymph node—skin cancer	0.000253	0.0131	CbGeAlD
Clomifene—Insomnia—Temozolomide—skin cancer	0.000252	0.00112	CcSEcCtD
Clomifene—Visual impairment—Docetaxel—skin cancer	0.000251	0.00112	CcSEcCtD
Clomifene—Tachycardia—Fluorouracil—skin cancer	0.000251	0.00111	CcSEcCtD
Clomifene—Paraesthesia—Temozolomide—skin cancer	0.00025	0.00111	CcSEcCtD
Clomifene—SIGMAR1—lymph node—skin cancer	0.000249	0.0128	CbGeAlD
Clomifene—Dyspnoea—Temozolomide—skin cancer	0.000248	0.0011	CcSEcCtD
Clomifene—Erythema multiforme—Docetaxel—skin cancer	0.000247	0.00109	CcSEcCtD
Clomifene—Body temperature increased—Dactinomycin—skin cancer	0.000244	0.00108	CcSEcCtD
Clomifene—Hypersensitivity—Bleomycin—skin cancer	0.000243	0.00108	CcSEcCtD
Clomifene—Flushing—Docetaxel—skin cancer	0.000242	0.00107	CcSEcCtD
Clomifene—Fatigue—Temozolomide—skin cancer	0.00024	0.00107	CcSEcCtD
Clomifene—CYP1A1—head—skin cancer	0.000239	0.0123	CbGeAlD
Clomifene—Constipation—Temozolomide—skin cancer	0.000238	0.00106	CcSEcCtD
Clomifene—Pain—Temozolomide—skin cancer	0.000238	0.00106	CcSEcCtD
Clomifene—Asthenia—Bleomycin—skin cancer	0.000237	0.00105	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000234	0.00104	CcSEcCtD
Clomifene—Pruritus—Bleomycin—skin cancer	0.000234	0.00104	CcSEcCtD
Clomifene—Arrhythmia—Docetaxel—skin cancer	0.000233	0.00103	CcSEcCtD
Clomifene—Insomnia—Fluorouracil—skin cancer	0.000232	0.00103	CcSEcCtD
Clomifene—Paraesthesia—Fluorouracil—skin cancer	0.000231	0.00102	CcSEcCtD
Clomifene—Alopecia—Docetaxel—skin cancer	0.000231	0.00102	CcSEcCtD
Clomifene—Dyspnoea—Fluorouracil—skin cancer	0.000229	0.00102	CcSEcCtD
Clomifene—Erythema—Docetaxel—skin cancer	0.000227	0.00101	CcSEcCtD
Clomifene—Hypersensitivity—Dactinomycin—skin cancer	0.000227	0.00101	CcSEcCtD
Clomifene—Urticaria—Temozolomide—skin cancer	0.000221	0.000983	CcSEcCtD
Clomifene—Asthenia—Dactinomycin—skin cancer	0.000221	0.000981	CcSEcCtD
Clomifene—Body temperature increased—Temozolomide—skin cancer	0.00022	0.000978	CcSEcCtD
Clomifene—ESR1—lymph node—skin cancer	0.00022	0.0114	CbGeAlD
Clomifene—Back pain—Docetaxel—skin cancer	0.00022	0.000975	CcSEcCtD
Clomifene—Pain—Fluorouracil—skin cancer	0.00022	0.000975	CcSEcCtD
Clomifene—CYP2E1—head—skin cancer	0.000218	0.0112	CbGeAlD
Clomifene—Diarrhoea—Dactinomycin—skin cancer	0.000211	0.000936	CcSEcCtD
Clomifene—Vomiting—Bleomycin—skin cancer	0.00021	0.000933	CcSEcCtD
Clomifene—CYP3A4—female reproductive system—skin cancer	0.00021	0.0108	CbGeAlD
Clomifene—Rash—Bleomycin—skin cancer	0.000208	0.000925	CcSEcCtD
Clomifene—Dermatitis—Bleomycin—skin cancer	0.000208	0.000924	CcSEcCtD
Clomifene—Hypersensitivity—Temozolomide—skin cancer	0.000205	0.000912	CcSEcCtD
Clomifene—Urticaria—Fluorouracil—skin cancer	0.000204	0.000906	CcSEcCtD
Clomifene—Syncope—Docetaxel—skin cancer	0.000204	0.000904	CcSEcCtD
Clomifene—Body temperature increased—Fluorouracil—skin cancer	0.000203	0.000901	CcSEcCtD
Clomifene—Palpitations—Docetaxel—skin cancer	0.000201	0.000891	CcSEcCtD
Clomifene—Asthenia—Temozolomide—skin cancer	0.0002	0.000888	CcSEcCtD
Clomifene—ABCB1—epithelium—skin cancer	0.0002	0.0103	CbGeAlD
Clomifene—Loss of consciousness—Docetaxel—skin cancer	0.0002	0.000886	CcSEcCtD
Clomifene—KCNH2—lymph node—skin cancer	0.000198	0.0102	CbGeAlD
Clomifene—Pruritus—Temozolomide—skin cancer	0.000197	0.000875	CcSEcCtD
Clomifene—Convulsion—Docetaxel—skin cancer	0.000197	0.000873	CcSEcCtD
Clomifene—Nausea—Bleomycin—skin cancer	0.000196	0.000871	CcSEcCtD
Clomifene—Hypertension—Docetaxel—skin cancer	0.000196	0.00087	CcSEcCtD
Clomifene—Vomiting—Dactinomycin—skin cancer	0.000196	0.00087	CcSEcCtD
Clomifene—Rash—Dactinomycin—skin cancer	0.000194	0.000862	CcSEcCtD
Clomifene—Arthralgia—Docetaxel—skin cancer	0.000193	0.000858	CcSEcCtD
Clomifene—Chest pain—Docetaxel—skin cancer	0.000193	0.000858	CcSEcCtD
Clomifene—Myalgia—Docetaxel—skin cancer	0.000193	0.000858	CcSEcCtD
Clomifene—Diarrhoea—Temozolomide—skin cancer	0.000191	0.000847	CcSEcCtD
Clomifene—Hypersensitivity—Fluorouracil—skin cancer	0.000189	0.00084	CcSEcCtD
Clomifene—Oedema—Docetaxel—skin cancer	0.000185	0.000823	CcSEcCtD
Clomifene—Dizziness—Temozolomide—skin cancer	0.000184	0.000818	CcSEcCtD
Clomifene—Nausea—Dactinomycin—skin cancer	0.000183	0.000813	CcSEcCtD
Clomifene—Shock—Docetaxel—skin cancer	0.000182	0.000809	CcSEcCtD
Clomifene—Pruritus—Fluorouracil—skin cancer	0.000182	0.000806	CcSEcCtD
Clomifene—Tachycardia—Docetaxel—skin cancer	0.000181	0.000803	CcSEcCtD
Clomifene—Vomiting—Temozolomide—skin cancer	0.000177	0.000787	CcSEcCtD
Clomifene—Rash—Temozolomide—skin cancer	0.000176	0.00078	CcSEcCtD
Clomifene—Diarrhoea—Fluorouracil—skin cancer	0.000176	0.00078	CcSEcCtD
Clomifene—Dermatitis—Temozolomide—skin cancer	0.000176	0.000779	CcSEcCtD
Clomifene—Headache—Temozolomide—skin cancer	0.000175	0.000775	CcSEcCtD
Clomifene—ABCB1—mammalian vulva—skin cancer	0.000173	0.00895	CbGeAlD
Clomifene—Dizziness—Fluorouracil—skin cancer	0.00017	0.000754	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000169	0.00075	CcSEcCtD
Clomifene—Insomnia—Docetaxel—skin cancer	0.000168	0.000744	CcSEcCtD
Clomifene—CYP1A1—lymph node—skin cancer	0.000167	0.00863	CbGeAlD
Clomifene—Paraesthesia—Docetaxel—skin cancer	0.000166	0.000739	CcSEcCtD
Clomifene—Nausea—Temozolomide—skin cancer	0.000166	0.000735	CcSEcCtD
Clomifene—Dyspnoea—Docetaxel—skin cancer	0.000165	0.000734	CcSEcCtD
Clomifene—Vomiting—Fluorouracil—skin cancer	0.000163	0.000725	CcSEcCtD
Clomifene—Rash—Fluorouracil—skin cancer	0.000162	0.000719	CcSEcCtD
Clomifene—Dermatitis—Fluorouracil—skin cancer	0.000162	0.000718	CcSEcCtD
Clomifene—Headache—Fluorouracil—skin cancer	0.000161	0.000714	CcSEcCtD
Clomifene—Fatigue—Docetaxel—skin cancer	0.00016	0.000709	CcSEcCtD
Clomifene—Constipation—Docetaxel—skin cancer	0.000158	0.000704	CcSEcCtD
Clomifene—Pain—Docetaxel—skin cancer	0.000158	0.000704	CcSEcCtD
Clomifene—ABCB1—lymphoid tissue—skin cancer	0.000154	0.00795	CbGeAlD
Clomifene—Nausea—Fluorouracil—skin cancer	0.000153	0.000677	CcSEcCtD
Clomifene—ABCB1—female reproductive system—skin cancer	0.000149	0.00767	CbGeAlD
Clomifene—Body temperature increased—Docetaxel—skin cancer	0.000147	0.00065	CcSEcCtD
Clomifene—Hypersensitivity—Docetaxel—skin cancer	0.000137	0.000606	CcSEcCtD
Clomifene—Asthenia—Docetaxel—skin cancer	0.000133	0.00059	CcSEcCtD
Clomifene—Pruritus—Docetaxel—skin cancer	0.000131	0.000582	CcSEcCtD
Clomifene—Diarrhoea—Docetaxel—skin cancer	0.000127	0.000563	CcSEcCtD
Clomifene—ABCB1—head—skin cancer	0.000124	0.0064	CbGeAlD
Clomifene—Dizziness—Docetaxel—skin cancer	0.000123	0.000544	CcSEcCtD
Clomifene—Vomiting—Docetaxel—skin cancer	0.000118	0.000523	CcSEcCtD
Clomifene—Rash—Docetaxel—skin cancer	0.000117	0.000519	CcSEcCtD
Clomifene—Dermatitis—Docetaxel—skin cancer	0.000117	0.000518	CcSEcCtD
Clomifene—Headache—Docetaxel—skin cancer	0.000116	0.000515	CcSEcCtD
Clomifene—Nausea—Docetaxel—skin cancer	0.00011	0.000489	CcSEcCtD
Clomifene—ABCB1—lymph node—skin cancer	8.69e-05	0.00448	CbGeAlD
